S. Bellino, S. Ziero, A. Ceregato, S. Colla, F. Bogetto - Vol. 7, Marzo 2001, num.1
Testo Immagini Bibliografia Summary Riassunto Indice
Il disturbo ossessivo-compulsivo con scarso insight:
indagine clinica su un gruppo di pazienti ambulatoriali
Obsessive-compulsive disorder with poor insight: a clinical investigation
of a group of outpatients
1 Lewis A. Problems of obsessional illness. Proceedings of Royal Society
of Medicine 1935;29:325-36.
2 Schneider K. Psicopatologia clinica. 2II edizione italiana corrispondente
alla VII edizione tedesca. Firenze: Sansoni Editore 1987.
3 Solyom L, DiNicola VF, Phil M, Sookman D, Luchins D. Is there an obsessive
Psychosis? Aetiological and prognostic factors of atypical form of obsessive-compulsive
neurosis. Can J Psychiatry 1985;30:372-80.
4 Tanzi E, Lugaro E. Trattato delle malattie mentali. Milano: Soc Editrice
Libraria 1923.
5 Robinson S, Winnik HA, Weiss AA. Obsessive psycosis. Israel Annals
of Psychiatry and related disciplines 1976;14:39-48.
6 Foa EB. Failures in treating obsessive-compulsives. Behav Res Ther
1979;17:169-76.
7 Kozak MJ, Foa EB. Obsessions, overvalued ideas, and delusions in obsessive-compulsive
disorder. Behav Res Ther 1994;32:343-53.
8 Insel TR, Akiskal HS. Obsessive-compulsive disorder with psychotic features:
a phenomenological analysis. Am J Psychiatry 1986;143:1527-33.
9 Eisen JL, Rasmussen SA. Obsessive-compulsive disorder with psychotic
features. Poster presented at the Meeting of the American Psychiatric
Association, San Francisco, CA, 1989.
10 Brugnoli R. La Clinica del DOC. In: Pancheri P, ed. Ossessioni,
compulsioni e continuum ossessivo. Roma: Il Pensiero Scientifico Editore
1992:51-87.
11 Eisen JL, Rasmussen SA. Obsessive-compulsive disorder with psychotic
features. J Clin Psychiatry 1993;54:373-9.
12 American Psychiatric Association. Diagnostic and statistical manual
of mental diseases (DSM-IV). 4th ed. Washington, DC: American Psychiatric
Press 1994.
13 Foa EB, Kozak MJ. DSM-IV field trial: obsessive compulsive disorder.
Am J Psychiatry 1995;152:90-6.
14 Maina G, Barzega G, Bellino S, Bogetto F, Ravizza L. Epidemiologia e
clinica del disturbo ossessivo-compulsivo. In: Ravizza L, Bogetto F, Maina
G, eds. Il disturbo ossessivo compulsivo. Milano: Masson 1997:9-43.
15 Catapano F, Sperandeo R, Di Martino S, Bartoli L, Maj M. Insight e resistenza
nei pazienti ossessivi. Giorn Ital Psicopatol 1996;2:126-32.
16 American Psychiatric Association. Diagnostic and statistical manual
of mental diseases (DSM III-R). 3rd ed. Washington, DC: American Psychiatric
Press 1987.
17 Goodman WK, Price LH, Rasmussen SA, Masure C, Fleischmann RL, Hill CL,
et al. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), I: development,
use, and reliability. Archives of General Psychiatry 1989;46:1006-11.
18 Goodman WK, Price LH, Rasmussen SA, Masure C, Delgado P, Heninger GR, et
al. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), II: validility.
Archiv Gen Psychiatry, 1989;46:1012-6.
19 First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Structured
Clinical Interview for DSM-IV Disorders (SCID). Washington, DC: American
Psychiatric Press 1997.
20 Hamilton M. A rating scale for depression. Journal of Neurology,
Neurosurgery and Psychiatry 1960;23:56-62.
21 Ravizza L, Maina G, Bogetto F. Episodic and chronic obsessive-compulsive
disorder. Depress Anxiety 1997;6:154-8.
22 Insel TR, Murphy DL, Cohen RM, et al. Obsessive-compulsive disorder:
a double-blind trial of clomipramine and clorgyline. Arch Gen Psychistry
1983;40:605-12.
23 Hamilton M. The assessment of anxiety states by rating. Br J Med
Psychol 1959;32:50-50-5.
24 Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The
Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry
1998;155:102-8.
25 Weiss EL, Potenza MN, McDougle CJ, Epperson CN. Olanzapine Addition
in Obsessive-Compulsive Disorder Refractory to Selective Seraotonin Reuptake
Inhibitors: An Open-Label Case Series. J Clin Psychiatry 1999;60:524-7.
26 Bogetto F, Bellino S, Vaschetto P, Ziero S. Olanzapine augmentation
of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open
trial. Psychiatry Research 2000;96:91-8.
27 McDougle CJ, Epperson CN, Pelton GH, et al. A double-blind, placebo-controlled
study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive
compulsive disorder. Archiv Gen Psychiatry 2000;57:794-801.
28 Jenike MA, Minichiello WE, et al. Concomitant obsessive-compulsive disorder
and schizotypal personality disorder.
Am J Psychiatry 1986;143:530-3.
29 Mc Dougle CJ, Goodman WK, Price LH. Neuroleptic addition in fluvoxamine-refractory
obsessive-compulsive disorder. Am J Psychiatry 1990;147:652-4.
30 Baer L, Jenike MA, Black DW, et al. Effect of Axis II diagnoses on treatment
outcome with clomipramine in 55 patients with obsessive compulsive disorder.
Arch Gen Psychiatry 1992;49:862-6.
31 Maina G, Bellino S, Bogetto F, Ravizza L. Personality disoredrs in obsessive-compulsive
patients: a study report. Eur J psychiatr 1993;7:155-63.
32 Orloff LM, Battle MA, Baer L, et al. Long term follow-up of 85 patients
with obsessive compulsive disorder. Am J Psychiatry 1994;151:441-2.